Cargando…
The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
The objective of this study was to determine the impact of calcium sensing receptor (CASR) A990G genetic polymorphism on parathyroid hormone (PTH) lowering response to cinacalcet treatment when controlling for significant influencing clinical factors. This retrospective study was conducted on 135 Th...
Autores principales: | Ngamkam, Jaruwan, Vadcharavivad, Somratai, Areepium, Nutthada, Auamnoy, Titinun, Takkavatakarn, Kullaya, Katavetin, Pisut, Tiranathanagul, Khajohn, Praditpornsilpa, Kearkiat, Eiam-Ong, Somchai, Susantitaphong, Paweena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429569/ https://www.ncbi.nlm.nih.gov/pubmed/34504264 http://dx.doi.org/10.1038/s41598-021-97587-8 |
Ejemplares similares
-
Effect of Maintenance Intravenous Iron Treatment on Erythropoietin
Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled
Trial
por: Susantitaphong, Paweena, et al.
Publicado: (2020) -
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis
por: Takkavatakarn, Kullaya, et al.
Publicado: (2023) -
A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria
por: Susantitaphong, Paweena, et al.
Publicado: (2017) -
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
por: Susantitaphong, Paweena, et al.
Publicado: (2019) -
Factors Associated with the Incidence and Mortality of Coronavirus Disease 2019 (COVID-19) after 126-million Cases: A Meta-analysis
por: Phannajit, Jeerath, et al.
Publicado: (2021)